در هنگام جستجو کلمه در قسمت عنوان میتوانید کلمات مورد جستجو را با کاراکتر (-) جدا کنید.
کاربرد نوع شرط:
- جایگاه : پژوهشی
- مجله: Iranian Journal of Pharmaceutical Sciences
- نوع مقاله: Journal Article
- کلمات کلیدی: Stock Return,panel data,Economic Variables,Fundamental analysis,Pharmaceutical companies,Stock exchange
- چکیده:
- چکیده انگلیسی: Stock return is usually considered to be affected by firm’s financial ratios as well as economic variables. Fundamental method assume that stock returns is not solely related to the stock market. Most result come from the company condition , industry situation and whole economy. In this paper, this relationship between stock return and fundamentals is studied using the data for 22 pharmaceutical companies in Tehran Stock Exchange over a 7 year period, and effective factors on stock return are investigated. Because of our data natural we used panel data model from econometric methods. The results show that 80 percent of change in stock return can be explained with 9 fundamental variables factors including debt-equity ratio, working capital to total asset, current ratio, net profit margin, operating cycle, market share, inflation rate of medicinal products prices, total asset, and exchange rate have significant effect on stock return. This factors can be used in decision making in pharmaceutical industry.
- انتشار مقاله: 26-11-1391
- نویسندگان: Abbas Kebriaeezadeh,Saman Zartab,S.Farshad Fatemi,Ramin Radmanesh
- مشاهده
- جایگاه : پژوهشی
- مجله: Iranian Journal of Pharmaceutical Sciences
- نوع مقاله: Journal Article
- کلمات کلیدی:
- چکیده:
- چکیده انگلیسی:
- انتشار مقاله: 14-04-1393
- نویسندگان: Khosro Keshavarz,Amir Hashemi Meshkini,Ramin Hayati,Somayeh Dehghan,Abbas Kebriaeezadeh
- مشاهده
- جایگاه : پژوهشی
- مجله: Iranian Journal of Pharmaceutical Sciences
- نوع مقاله: Journal Article
- کلمات کلیدی: Gas chromatography,Determination,Valproic acid,Human plasma
- چکیده:
- چکیده انگلیسی: A simple, reproducible and rapid gas chromatographic method for precise determination of valproic acid (VPA) in human plasma has been developed. Total time for sample preparation and GC analysis is less than 45 min. After plasma protein precipitation, VPA was extracted into chloroform with suitable recovery. By using Stabilwax®-DA capillary GC column, a symmetrical gas chromatographic peak was obtained without the need for derivatization. The calibration curve was proved to be linear (r2 = 0.998) in a wide concentration range (0.45-100 μg/ml). Inter-day and intra-day accuracy and precision of this method was investigated during the method validation and the method has good precision and accuracy. This method is highly reproducible with a limit of detection 150 ng/ml of VPA in human plasma and could be used in TDM and pharmacokinetic studies.
- انتشار مقاله: 20-05-1385
- نویسندگان: Reza Ahmadkhaniha,Noushin Rastkari,Farzad Kobarfard,Hossein Pakdaman,Omid Ahmadkhaniha,Abbas Kebriaeezadeh
- مشاهده
- جایگاه : پژوهشی
- مجله: International Journal of Pediatrics
- نوع مقاله: Journal Article
- کلمات کلیدی: children,Developing countries,Developed Countries,Costs,Acute Lymphocytic Leukemia
- چکیده:
- چکیده انگلیسی: Background
Pediatric acute lymphoblastic leukemia (ALL) is the most common, yet curable childhood malignancy within the pediatric cancers; but in most developed and developing countries cost of cancer treatment in children with ALL is high. So, we specified the range of expenses for the treatment of pediatric cancer and compared the results in developed and developing countries.
Materials and Methods
To evaluate treatment costs in childhood ALL, a review was taken place through published papers during the years 2000 to 2015. We searched multiple well known databases such as Medline, Scopus, ISI Web of Science and Google Scholar on January 2015 with "cost effectiveness", "cost utility", "cost minimization", "cost analysis", "economic evaluation", "childhood", "acute lymphoblastic leukemia", and "ALL" as our keywords.
Results
Regarding the reviewed evidence the essential result was that the total costs for treatment of pediatrics ALL in developing countries such as Asian countries were considerably lower than the costs reported from high income countries in Europe and North America. So different protocols were performed to treat ALL and this matter was significant due to the different durations of hospitalization.
Conclusion
According to the results, the total costs for treatment of pediatrics ALL in developing countries were considerably lower than the costs reported from high income countries.- انتشار مقاله: 08-08-1395
- نویسندگان: Hadi Hayati,Abbas Kebriaeezadeh,Mohammad Ali Ehsani,Shekoufeh Nikfar,Ali Akbari Sari,Mehdi Troski,Bereket Molla Tigabu
- مشاهده
- جایگاه : پژوهشی
- مجله: International Journal of Pediatrics
- نوع مقاله: Journal Article
- کلمات کلیدی: Pediatrics,Acute Lymphocytic Leukemia,ALL-BFM,Cost-analysis
- چکیده:
- چکیده انگلیسی: Background
Among all pediatric cancers acute lymphoblastic leukemia (ALL) is highly prevalent, butthe overall cost of ALL management is not well-known, there is a need to assess the Berlin-Frankfurt-Munster (BFM) protocol commonly used in ALL management in Iran. So, the aim of this study was to estimate direct and indirect costs of ALL treatment among children based on the ALL-BFM protocol from the societal perspective in Iran.
Materials and Methods
A retrospective study was conducted. All pediatric patients newly diagnosed with ALL and managed by the BFM protocol from 2010-2015 were included. Finally, total costs, including direct medical costs, direct non-medical costs and indirect costs were calculated.
Results
The total direct medical cost per patient for a complete treatment period was 15,026.6US dollars, the direct non-medical cost incurred was 1,688.9 USD and the indirect cost due to productivity loss was 932.3 USD.
Conclusion
Treatment of pediatrics ALL is less costly in Iran comparing other countries. So, physicians and policy makers and health care system administrators should devise an appropriate strategy to reduce the direct medical costs which have more economic burden special for hospitalization days and chemotherapy costs based on the findings.- انتشار مقاله: 02-05-1395
- نویسندگان: Hadi Hayati,Abbas Kebriaeezadeh,Mohammad Ali Ehsani,Shekoufeh Nikfar,Azim Mehrvar
- مشاهده